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The divalent anion sodium symporter (DASS) 
family (SLC13) play critical roles in metabolic 
homeostasis, influencing many processes including 
fatty acid synthesis, insulin resistance, and 
adiposity. DASS transporters catalyse the Na+-
driven concentrative uptake of Krebs cycle 
intermediates and sulfate into cells; disrupting their 
function can protect against age-related metabolic 
diseases and can extend lifespan. An inward-facing 
crystal structure and an outward-facing model of a 
bacterial DASS family member, VcINDY from 
Vibrio cholerae, predict an elevator-like transport 
mechanism involving a large rigid body movement 
of the substrate binding site. How substrate binding 
influences the conformational state of VcINDY is 
currently unknown. Here, we probe the interaction 
between substrate binding and protein 
conformation by monitoring substrate-induced 
solvent accessibility changes of broadly distributed 
positions in VcINDY using a site-specific 
alkylation strategy. Our findings reveal that 
accessibility to all positions tested are modulated by 
the presence of substrates, with the majority 
becoming less accessible in the presence of 
saturating concentrations of both Na+ and 
succinate. We also observe separable effects of 
Na+ and succinate binding at several positions 
suggesting distinct effects of the two substrates. 
Furthermore, accessibility changes to a solely 
succinate-sensitive position suggests that substrate 
binding is a low affinity, ordered process. Mapping 
these accessibility changes onto the structures of 
VcINDY suggests that Na+ binding drives the 
transporter into an as-yet-unidentified 
conformational state, involving rearrangement of 
the substrate binding site-associated re-entrant 
hairpin loops. These findings provide insight into 
the mechanism of VcINDY, which is currently the 
only structural-characterised representative of the 




The divalent anion sodium symporter (DASS) 
family of transporters are present in all domains of 
life and are responsible for the transport of several 
key compounds into cells, such as citrate, Krebs 
cycle intermediates and sulfate1. Cytoplasmic 
citrate plays a major role in the metabolism of 
eukaryotic cells, contributing to the regulation of 
fatty acid, cholesterol and low-density lipoprotein 
synthesis2-5. By maintaining and controlling the 
cytoplasmic citrate concentration, members of the 
DASS family (Transport Classification Database 
no. 2.A.47, SLC13 in humans) are key players in 
metabolic regulation in eukaryotes as demonstrated 
by the phenotypes associated with their functional 
disruption. Knockdown of a DASS family member 
in fruitflies and nematodes leads to phenotypes 
analogous to caloric restriction, most notably a 
substantial increase in the lifespan of the organism, 
hence the alternative name for this family, INDY, 
which stands for I’m not dead yet6,7. In mice, 
knockout of a DASS family member (NaCT, 
SLC13A5 in humans) leads to protection against 
adiposity and insulin resistance6, and knockout of 
the equivalent transporter in human 
hepatocarcinoma cells substantially reduces 
hepatoma cell proliferation and colony formation7. 
Thus, DASS family members are prime targets for 
therapeutics designed to tackle metabolic diseases 
including diabetes and obesity, and liver cancer.  
DASS transporters are ion-coupled secondary 
active transporters. Secondary transporters can 
harness the energy stored in ion gradients (usually 
Na+ or H+) across the membrane to drive the 
energetically uphill movement of substrate against 
its concentration gradient. Secondary active 
transporters must occupy at least two major 
conformational states, the inward-facing state (IFS) 
and the outward-facing state (OFS), which alternate 
in order to expose the substrate binding site from 
the cytoplasmic to the extracellular side of the 
membrane, and vice versa.  
The DASS transporter family belongs to the Ion 
Transporter (IT) Superfamily8,9, and the majority of 
characterised DASS transporters are known to 
transport their anionic substrates coupled to the co-
transport of multiple Na+ ions10,11-15. However, 
some members of the DASS family are known to 
catalyse substrate exchange, for example, the 
recently structurally characterised LaINDY, which 
is predicted to be an a-ketoglutarate/dicarboxylate 
exchanger16. The majority of our structural and 
mechanistic understanding of the DASS family 
comes from studies on a bacterial family member, 
VcINDY, from Vibrio cholerae, which is the only 
DASS co-transporter for which we have high-
resolution structural information17,18. Functional 
characterisation of VcINDY reveals it 
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preferentially transports C4-dicarboxylates, for 
example, succinate, malate and fumarate15. The 
model VcINDY substrate, succinate, is transported 
in its dianionic form coupled to the transport of 
three Na+ ion15,19. Our labs and others have revealed 
that VcINDY shares structural and functional 
characteristics with its mammalian homologues, 
suggesting that insight derived from the mechanism 
of VcINDY is directly applicable to the mammalian 
transporters15,19,20. 
The x-ray structures of VcINDY reveal that it forms 
a homodimer and each protomer consists of two 
domains; the scaffold domain that forms dimer 
interface contacts, and the transport domain that 
houses key substrate binding residue (Fig. 1A)16-18. 
All structures of VcINDY to date are captured in 
the same IFS conformation where the substrate is 
exposed to the cytoplasmic side of the membrane 
suggesting that the crystallisation conditions select 
for this lowest free-energy state conformation of 
VcINDY16-18. Using a combination of symmetry-
based structural modelling and extensive 
biochemical and biophysical validation, we have 
described an OFS conformation of VcINDY in 
which the transport domain and the substrate 
binding site are vertically translocated through the 
membrane (Fig. 1A)21. Combined, the IFS structure 
and OFS model predict that VcINDY employs an 
elevator-like mechanism to achieve alternating 
access to the substrate binding site from both sides 
of the membrane. Recent structural characterisation 
of the DASS exchanger, LaINDY, revealed an OFS 
structurally very similar to the OFS predicted for 
VcINDY, strongly supporting the elevator-like 
mechanism for VcINDY and the DASS family in 
general16. 
The structures of VcINDY reveal that the substrate 
binding site within the transport domain is 
composed of backbone and side chain contacts 
from the tips of two re-entrant hairpin loops and an 
unwound helix (TM 7)17. This organisation is 
reminiscent of other elevator-like ion-driven 
transporters where local conformational changes of 
hairpin loops are required for ligand binding, 
controlling coupling ion and substrate access to the 
binding site, and as a means of preventing 
uncoupled transport22-24. However, the x-ray 
structures of VcINDY reveal that, unlike these 
other elevator-like transporters, VcINDY’s hairpin 
loops do not fully enclose the bound substrates, nor 
is there any structural evidence that they are 
involved in gating binding site access17,18. The 
transport of substrate and coupling ion is tightly 
coupled, meaning that Na+ transport cannot occur 
without succinate transport, and vice versa. In a 
simple kinetic scheme for VcINDY; succinate2- and 
3 Na+ ions bind to the OFS (Fig 1 B, step 1), 
facilitating a conformational change into the IFS 
via an intermediate occluded state that is yet to be 
structurally characterised (Fig 1 B, step 2, 3). The 
substrates are released from the IFS (Fig 1 B, step 
4), and the empty transporter transitions back to the 
OFS via an occluded intermediate state (Fig 1 B, 
step 5, 6). The key to tightly coupled transport is 
that the IFS-to-OFS transition cannot occur unless 
the transporter either is ligand-free or carrying its 
full complement of substrate and coupling ions. 
What remains to be determined is how the presence 
of substrates influences the conformational state of 
VcINDY and whether local conformational 
changes of the re-entrant hairpins are required for 
transport. 
Site-directed alkylation of single cysteine residues 
has been a valuable tool in elucidating the dynamic 
features of transporters, in particular the pioneering 
work on lactose permease by Kaback and co-
workers25,26. Alkylation of single cysteine residues 
provides a readout of the accessibility of a 
particular position on the protein. The reactivity of 
single cysteine residues to hydrophilic thiol-
reactive reagents depends on the solvent 
accessibility of the amino acid residue in a given 
conformation. Thus, any change in the reactivity 
between the cysteine and the thiol-reactive reagent 
reflects a change in the local environment and/or 
solvent accessibility to that particular position in 
the protein. 
Here, we sought to explore the substrate 
dependence of the elevator-like conformational 
changes of VcINDY. To achieve this, we employed 
the hydrophilic, thiol-reactive reagent, 
methoxypolyethylene glycol maleimide 5K 
(mPEG5K) to probe the solvent accessibility of 
substituted single cysteines that are predicted to be 
accessible in the IFS or the OFS, but not both, 
according to the IFS crystal structure and OFS 
model. Our findings are consistent with VcINDY 
entering a structurally uncharacterised 
conformation upon binding substrates, with the 
majority of these accessibility changes being 
induced by binding Na+ alone. Several positions 
towards the tips of the hairpin loops were identified 
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that, unlike all other positions tested, displayed 
substantial sensitivity to the binding of succinate 
over and above the sensitivity to Na+ binding. 
Taken together, these observations are consistent 
with a transport mechanism that involves multiple 
conformational changes that differ in their substrate 
dependence. In addition, our findings suggest that 
Na+ must bind prior to succinate and that 
dicarboxylate substrates appear to bind with a 




Experimental approach and generation of 
substituted cysteine panel. In this work, we sought 
to determine whether the presence of substrates 
drives VcINDY predominantly into its IFS, its 
OFS, or into an intermediate conformational state 
that has not yet been structurally characterised. To 
probe the conformational state of VcINDY, we 
devised a substituted cysteine solvent accessibility 
assay in which we could measure the rate of 
modification of substituted cysteine residues using 
a hydrophilic cysteine reactive mass tag, mPEG5K, 
in the presence and absence of substrates (Fig. 2A). 
The reaction between an accessible single cysteine 
residue and mPEG5K would result in a 5 kDa 
increase in protein mass that is discernible on SDS-
PAGE due to the PEGylated protein’s retarded 
electrophoretic mobility (Fig. 2B). Digitisation and 
densitometric analysis of the distribution of bands 
in each sample allows us to quantify the extent of 
PEGylation and calculate a modification efficiency 
for each timepoint (Fig. 2C). Plotting the 
modification efficiency for each sample in a 
timecourse provides us with a means of monitoring 
the modification rate of a particular position on the 
protein, which reflects the relative solvent 
accessibility of that position. 
To allow us to differentiate between the IFS and 
OFS, we selected residues predicted to be 
accessible in the IFS or the OFS, but not both, using 
the IFS crystal structure and OFS repeat-swapped 
model as guides17,21. While avoiding highly 
conserved residues or residues involved in substrate 
or cation binding, we selected 24 amino acids in 
VcINDY to be individually substituted for cysteine, 
using a functionally active cysteine-free version of 
VcINDY as a background (see Table 1 for a full list 
of mutants tested)15. Of the 24 single cysteine 
variants produced, we discarded those mutants that 
were not produced in sufficient quantities for 
analysis, were incapable of catalysing Na+-driven 
succinate transport, or were not reactive to 
mPEG5K under any conditions (Table 1). 
Following this sieving step, we were left with 8 
single cysteine mutants; VcINDYA120COFS, 
VcINDYT215COFS, VcINDYS381COFS, 
VcINDYL384COFS, VcINDYV388COFS that are 
predicted to be more accessible in the OFS (OFS 
denoting that they are predicted to be OFS-
accessible cysteines); VcINDYT154CIFS, 
VcINDYM157CIFS, and VcINDYT177CIFS that are 
predicted to be more accessible in the IFS (IFS 
denoting their predicted IFS accessibility); and a 
control cysteine mutant, VcINDYE42C, which is 
predicted to be equally accessible in both IFS and 
OFS. Importantly, all of the single cysteine mutants 
used in this analysis were capable of catalysing 
Na+-driven succinate transport, demonstrating that 
they can sample conformations essential for 
transport (Supplementary Figure 1). Using this 
panel of substituted cysteine mutants and the 
experimental approach described above, we sought 
to determine whether the presence or absence of 
substrates (Na+ and succinate) drives VcINDY into 
the IFS, OFS, or a hitherto unidentified 
intermediate. 
 
Accessibility to all sites is substantially reduced 
in the presence of saturating substrate 
concentrations. To provide us with a readout on 
the conformational state of VcINDY, we selected 
two mutants for initial analysis that, based on 
available structural information, we predict are only 
accessible in the IFS or the OFS; VcINDYT154CIFS 
(Fig 3A, left) and VcINDYS381COFS (Fig. 3A, 
middle), respectively. To assess substrate-induced 
changes to the modification efficiency of these 
positions, we incubated each mutant protein with 
saturating substrate concentrations (1 mM 
succinate, 150 mM NaCl) or under apo conditions 
(no succinate and with Na+ ions replaced with 
experimentally inert K+), and quantified the rates of 
modification using SDS-PAGE and densitometric 
analysis (Fig. 3 B and C). 
In the apo state, we observe substantial PEGylation 
of the IFS-accessible VcINDYT154CIFS over the 
timecourse of the experiment resulting in 
PEGylation of ~65% of the protein (Fig. 3C, left, 
blue data, expressed as modification efficiency, 
which is acting as surrogate for modification rate). 
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However, in the presence of saturating substrates, 
PEGylation of this position was almost completely 
prevented, suggesting that VcINDY favours a 
conformation in which T154 is not solvent 
accessible under these conditions (Fig. 3C, left, 
grey data). 
Based on our current understanding of the structural 
mechanism of VcINDY, these data suggest that the 
presence of substrates drives VcINDY into a non-
IFS conformation, which, based on our 2-state 
model, is the OFS. We reasoned that if this change 
in accessibility of T154C is indeed due to a rigid 
body elevator-like movement of VcINDY’s 
transport domain, then we should observe the 
opposite effect of substrates on a single cysteine in 
a position predicted to be accessible in the OFS, but 
not in the IFS. To test this hypothesis, we analysed 
the PEGylation rate of the OFS-accessible cysteine 
variant VcINDYS381COFS, in the presence and 
absence of substrates. In the absence of substrates, 
we observed a steady labelling rate of 
VcINDYS381COFS over the course of our 
experiment (Fig. 3B and C, middle panel). 
However, instead of seeing a further increase in the 
modification rate upon addition of substrate, which 
would be consistent with our hypothesis, we 
observe that labelling of VcINDYS381COFS is 
almost completely blocked in the presence of Na+ 
and succinate (Fig. 3B and C, middle panel). 
To rule out the possibility that the presence of 
substrate could be directly diminishing the 
reactivity of mPEG5K through some unforeseen 
mechanism, we performed our PEGylation assay on 
VcINDYE42C, whose single cysteine is predicted 
to be equally accessible in both of the known 
conformations of VcINDY (Fig. 3A, right). For this 
control mutant, we observed equal PEGylation 
rates in the presence and absence of substrates, 
indicating that the effect on the modification 
efficiency of our IFS- and OFS-accessible mutants 
is indeed due to interaction of the substrate with 
VcINDY (Fig. 3B and C, right panel).  
Intriguingly, our data for VcINDYT154CIFS and 
VcINDYS381COFS indicates that both positions 
become less accessible in the presence of 
substrates, which is consistent with VcINDY 
adopting an as-yet-unknown intermediate 
conformational state in the presence of substrates. 
To explore this possibility further, we analysed the 
modification rates of the 6 other VcINDY variants 
with single cysteines positioned in sites spanning 
the scaffold domain-transport domain interface; 
two predicted to be only accessible in the IFS, and 
4 OFS-accessible only (Fig. 4A). Each of these 6 
cysteine variants could be robustly PEGylated in 
the absence of substrates with final proportions of 
PEGylated protein ranging between 60-85%; these 
variations likely reflect the relative solvent 
accessibility of each position (Supplementary 
figures 2A and 3). While we also observed mutant-
to-mutant variation in the magnitude of substrate-
induced modification efficiency changes, all of the 
positions tested exhibited substantially reduced 
levels of modification in the presence of substrates 
compared to the absence, signified by a negative 
∆modification efficiency value (Fig. 4B). These 
results indicate that all of the positions tested are 
less solvent accessible in the presence of substrates, 
further suggesting that VcINDY favours a 
conformational state substantially different to the 
currently known conformations of VcINDY. 
 
Modification rates are influenced by the 
presence of Na+. To investigate the substrate-
induced changes in modification efficiency in more 
detail, we sought to determine the individual effects 
of the coupling ion, Na+, and the substrate, 
succinate, on the modification efficiency of each 
substituted cysteine. To do this, we measured the 
PEGylation rate of our panel of single cysteine 
mutants in one of 4 different conditions; Na+ alone; 
succinate alone; apo; or Na+ and succinate. In each 
case, we ensured that the reactions were 
osmotically and ionically balanced using KCl, 
which is known not to catalyse transport nor 
interact specifically with VcINDY15,19. 
We first analysed the effects of coupling ion or 
substrate on the modification rates of the IFS- and 
OFS-accessible mutants, VcINDYT154CIFS (Fig. 
5A) and VcINDYS381COFS (Fig. 5B). For these 
two mutants, we observed no changes in the 
modification rate in the presence of succinate alone 
when compared to apo conditions (Fig. 5A and B). 
However, the presence of Na+ alone substantially 
reduced the modification rate of these mutants, 
accounting for almost all of the reduction in the 
modification rate we observed in the presence of 
both Na+ and succinate (Fig. 5A and B). These data 
suggest that the presence of Na+ alone is able to 
induce a shift in the protein’s conformation that 
obscures these positions and reduces modification 
efficiency, whereas succinate binding by itself 
 6 
contributes minimally. In addition, the observation 
that succinate alone is unable to influence the 
modification rate of these positions indicates that 
one or more Na+ ions must bind to VcINDY prior 
to succinate binding. We next tested the other 
members of our single cysteine panel to see if Na+ 
binding also reduced their modification rate. In 
total, Na+ binding alone accounted for the majority 
of substrate-induced modification rate changes in 
half of the single cysteine mutants, including; two 
IFS-accessible mutants, VcINDY154CIFS and 
VcINDY177CIFS, and two OFS-accessible mutants, 
VcINDYA120COFS, VcINDYS381COFS (Fig. 5C).  
In addition to Na+-induced modification rate 
changes, 3 members of our mutant panel, 
VcINDY215COFS, VcINDY384COFS, and 
VcINDY388COFS also exhibited further substantial 
modification rate reduction upon addition of 
succinate in the presence of Na+. These additional 
succinate-induced modification rate changes 
strongly suggest that the sequential binding of each 
substrate stabilises discrete conformations of 
VcINDY. 
Interestingly, the amino acid positions that exhibit 
separable sensitivity to both Na+ and succinate are 
located on the arms of the re-entrant hairpin loops 
that contribute to binding site formation, raising the 
possibility that the observed accessibility changes 
are due to substrate-induced local conformational 
changes of the hairpin loops. While this is the first 
evidence suggesting hairpin loop movement in 
VcINDY’s mechanism, hairpin loops have been 
shown to perform a pivotal role in gating and 
coupling in other elevator-like transporters23-25.  
In contrast to all other positions tested, the 
modification efficiency of one of these re-entrant 
hairpin loop residues, VcINDYM157CIFS, was 
completely insensitive to the presence of Na+ ions 
alone, but exhibited substantial succinate 
sensitivity in the presence of 150 mM Na+ (Fig. 5C 
and 6A). Succinate did not induce changes in the 
modification rate of VcINDYM157CIFS in the 
absence of Na+, again suggesting an ordered 
binding process in which one or more Na+ must 
bind prior to succinate binding (Fig. 5C and 6A). 
As these data were collected using detergent-
solubilised protein, we wanted to determine 
whether we could observe the same substrate-
dependent effects on accessibility in a lipid bilayer. 
To test this, we extracted two of the more intriguing 
mutants, VcINDYM157CIFS, which is highly 
sensitive to succinate, and VcINDYA120COFS, 
which is highly sensitive to Na+, from the lipid 
bilayer using styrene maleic acid (SMA) co-
polymer to generate native nanodiscs27. Using our 
nanodisc embedded mutants, we found that the 
substrate-induced modulation of the PEGylation 
rate in nanodiscs mirrored the observation in 
detergent; the presence of Na+ decreased the 
accessibility of VcINDYA120COFS (Fig 5D, 
Supplementary figure 2B), and the presence of 
succinate reduced the accessibility of 
VcINDYM157CIFS (Fig. 5E, Supplementary figure 
2B). These data demonstrate that the effects of 
substrates on residue accessibility in a detergent 
environment is a good representation of the effects 
in a more physiological setting of the lipid bilayer. 
While our data are consistent with the different 
substrate conditions stabilising particular 
conformations of VcINDY, an alternative 
possibility is that, in the presence of substrates, the 
fully loaded transport undergoes rapid IFS-OFS 
interconversion; so rapid perhaps that the 
maleimide, which has a relatively slow rate of 
reaction, does not have sufficient time to react, 
which would result in apparent inaccessibility. To 
test this possibility, we performed our PEGylation 
assay on VcINDYM157CIFS in the presence and 
absence of succinate using MTS-PEG5K, whose 
methanethiosulfonate (MTS) moiety has a 
considerably faster reaction rate than maleimides28. 
Under these conditions, we observed the same 
decrease in modification efficiency in the presence 
of succinate compared to the absence 
(Supplementary Figure 4), indicating that our 
observations with mPEG5K reflect conformational 
stabilisation rather than altered protein dynamics. 
 
PEGylation rates of VcINDYM157CIFS suggest 
ordered low affinity binding of succinate. Due to 
the maverick nature of the VcINDYM157CIFS 
mutant, we investigated this variant in more detail. 
To determine whether the apparent succinate-
induced decrease in modification efficiency was 
due to a specific interaction between VcINDY and 
succinate, we performed our PEGylation assay on 
VcINDYM157CIFS in the presence of increasing 
concentrations of succinate ranging from no 
succinate up to 1 mM, while keeping a constant Na+ 
concentration of 150 mM (Fig 6 B).  
We observed a dose-dependent decrease in 
modification efficiency of VcINDYM157CIFS with 
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increasing succinate concentration, indicating that 
this effect is indeed due to succinate binding (Fig. 
6B). However, substantial reduction in the 
modification efficiency is only apparent when the 
protein is incubated with ³100 µM succinate, 
suggesting an unexpectedly low affinity for 
succinate, considering the Km for transport is known 
to be 1 µM15. This apparent low affinity is 
unexpected and, despite the M157C mutant 
retaining the ability to catalyse Na+-driven 
transport, we considered the possibility that 
mutating this position in the arm of this re-entrant 
loop could interfere with substrate interactions and 
cause this low affinity interaction. To investigate 
this possibility, we determined the binding affinity 
of VcINDY wildtype using microscale 
thermophoresis (MST), which revealed a Kd of 4.3 
± 1.5 mM for succinate in the presence of 150 mM 
Na+, whereas no binding was observed for the non-
substrate oxalate (Fig. 6C). These data reveal that 
both VcINDY wildtype and the M157C mutant 
have a binding affinity in the same mM range, 
demonstrating that the cysteine substitution in this 
position did not dramatically affect substrate 
interactions. 
In addition to succinate, VcINDY can transport a 
number of other C4-dicarboxylates, including 
malate, fumarate, and oxaloacetate, but not shorter 
dicarboxylates, such as oxalate, nor tricarboxylates, 
such as citrate15. If the decrease in PEGylation rate 
is indeed due to VcINDY’s specific interaction with 
its substrates, we would expect other known 
substrates to be similarly influential, whereas non-
transported dicarboxylates should have no effect. 
Compared to Na+ alone conditions, substituting 
succinate with malate in the PEGylation reaction 
resulted in a significant increase in the modification 
rate, whereas substituting succinate with the non-
substrate oxalate resulted in modification rates akin 
to those observed in the absence of any 
dicarboxylate substrate (Fig. 7A). These data 
indicate that the reduction in modification rate of 
VcINDYM157CIFS are due to specific substrate 
interactions and not due to unforeseen indirect 
effects of dicarboxylates. However, we noted with 
interest that the presence of malate led to 
substantially and significantly reduced protection 
of the cysteine from PEGylation compared to 
succinate (Fig. 7A).  
Intrigued by this result, we extended the compound 
range in our VcINDYM157CIFS PEGylation assay 
to include the other known VcINDY substrates, 
fumarate and oxaloacetate, and another non-
substrate citrate (Fig. 7B). To test the effects of our 
extended compound range on the 
VcINDYM157CIFS PEGylation rate, we 
determined the modification efficiency after 60 min 
incubation with mPEG5K and 1 mM of each test 
compound (Fig. 7C, open bars). As expected, the 
presence of succinate reduces the modification to 
the greatest extent, whereas oxalate, citrate, and 
surprisingly, oxaloacetate induce negligible 
changes to the modification efficiency compared to 
the absence of substrates (Fig. 7C). The presence of 
1 mM fumarate and malate reduce modification 
efficiency substantially, but only half as much as 
succinate (Fig. 7C). We reasoned that these 
variations in the extent of labelling in the presence 
of different substrates could merely reflect 
differences in the affinity for each of the different 
substrates. To test this possibility, we performed the 
same PEGylation assay, but with a final 
concentration of 10 mM of each compound (Fig. 
7C, closed bars). In the presence of increased 
concentrations of each compound, we observe no 
change in the modification efficiency in the 
presence of either oxalate nor citrate (Fig. 7C). 
Increasing the concentration of oxaloacetate to 10 
mM results in significantly decreased modification 
efficiency compared to 1 mM, and while increasing 
the concentration of fumarate and malate to 10 mM 
leads to further reduction in the modification 
efficiency, they were still significantly less 
effective than 10 mM succinate (Fig. 7C). These 
data suggest that the differences in the modification 
efficiency of VcINDYM157CIFS in the presence of 
different substrates is due primarily to differences 
in VcINDY’s binding affinity for each substrate. In 
addition, these results reveal that VcINDY’s 
substrate binding site is not saturated in the 
presence of 1 mM substrate, suggesting that under 
these experimental conditions, VcINDY has a 




In this work, we have described the first foray into 
determining the substrate-dependent 
conformational changes of VcINDY, which is a 
structural and mechanistic representative of the 
DASS transporter family. Using a site-specific 
alkylation strategy on detergent-solubilised protein, 
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we have demonstrated that the modification rate, 
which serves as a proxy for solvent accessibility, of 
several broadly distributed positions in VcINDY 
can be modulated by the presence of substrates. We 
demonstrate that the majority of these changes in 
modification efficiency can be induced by the 
presence of Na+ alone. However, we also observe 
substantial, separable effects of succinate binding 
on the modification efficiency of multiple 
positions, suggesting discrete effects of the two 
substrates. Furthermore, we have identified a 
position whose modification rate is insensitive to 
the presence of Na+, but highly sensitive to 
succinate. Further analysis of this variant indicates 
that substrate binding by VcINDY is an ordered 
process in which one or more Na+ ions must bind 
prior to the substrate, succinate. In addition, 
substrate titration with this succinate-sensitive 
variant reveals that it binds its substrate with a low 
affinity; a finding supported by binding analysis of 
wildtype VcINDY. Interestingly, the changes in 
solvent accessibility for the panel of mutants tested 
cannot be reconciled by a simple switch between 
the IFS structure and the OFS model. Therefore, our 
data are consistent with a more complex multi-step 
transport mechanism that involves local 
conformational changes of the re-entrant hairpin 
loops and possibly the formation of an intermediate 
state; a model strongly supported by recent 
structures of DASS family members. 
 
VcINDY likely undergoes multiple large- and 
small-scale conformational changes during 
transport. There are now many examples of 
structurally characterised transporters that are 
predicted to employ an elevator-like transport 
mechanism24,29-38, which has revealed common 
features amongst many of them, including; distinct 
scaffold and transport domains, a broken 
transmembrane helix containing an intramembrane 
loop that contributes to the substrate binding site, 
and two re-entrant hairpin loops that enter the 
membrane but do not fully span it. While structural 
differences exist between the predicted elevator-
type transporters, they are all predicted (or have 
been shown) to undergo a substantial vertical 
translocation of the transport domain, usually 
accompanied by a pronounced rotation of this 
domain, to expose the substrate binding site to both 
sides of the membrane.  
Our data suggest that multiple positions predicted 
to be solvent accessible in either the IFS or the OFS, 
but not both, of VcINDY become less accessible in 
the presence of Na+ (Fig. 4), consistent with the 
stabilisation of the an as-yet-unidentified 
conformation of VcINDY that could represent an 
intermediate state. Cation-dependent 
conformational changes have been observed for 
multiple Na+-driven elevator-like transporters39-41. 
By occupying an intermediate state between the IFS 
and OFS, many of the residues tested could be 
obscured, leading to reduced modification. No 
intermediate state structure exists for VcINDY, so 
we cannot map the required conformational 
changes directly onto a structure of VcINDY. 
However, intermediate states of other elevator-like 
transporters, either crosslink-stabilised or captured 
in the presence of substrate33,42, have been 
structurally characterised, demonstrating that an 
intermediate state is well-occupied during the 
elevator-like mechanism. Indeed, in the case of the 
best-characterised elevator transporter, GltPh, the 
protein only transitions between the OFS and 
intermediate state, or the IFS and intermediate state 
in the presence of Na+ alone41. Only when both the 
cation and substrate are present can the protein fully 
transition between the IFS and OFS (via the 
intermediate state)41. This blockage of the cation 
only-bound state is crucial to tight coupling in 
secondary active transporters and prevents cation 
leak, which could prove catastrophic to the cell. 
In both VcINDY and GltPh, the tips of these re-
entrant loops form part of the substrate binding site, 
coordinating both the coupling ion and 
substrate17,18,43. However, a major mechanistic 
difference between VcINDY and GltPh is the role of 
the re-entrant loops in gating and coupling. In GltPh 
and other glutamate transporter homologues, the 
substrate and coupling ions are fully enclosed in the 
transport domain23,43-45. An OFS crystal structure of 
GltPh in the presence of the bulky inhibitor D,L-
threo-b-benzyloxyaspartate (TBOA) revealed that 
the outermost re-entrant loop, HP2, could be 
propped open to allow substrate access to the 
binding site23. The local and relatively subtle 
conformational changes of this hairpin are crucial 
to tight coupling of these transporters; the re-entrant 
loop is “open” in the absence of the full 
complement of substrate and coupling ions, which 
prevents premature translocation of the binding site 
that would lead to uncoupled transport. The 
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symmetrically related re-entrant loop, HP1, was 
thought to play a similar role on the cytoplasmic 
face of the transporter. However, recent structural 
analysis of the human neutral amino acid 
transporter (ASCT2), which is structurally related 
to GltPh, revealed that HP2 is also required to open 
in the IFS; whereas HP1 remains static24. 
In the IFS structure and OFS model of VcINDY, 
the substrate is solvent exposed and straddles the 
interface of the scaffold and transport 
domains17,18,21, potentially precluding the need for 
hairpin-coordinated gating in DASS transporters. 
In this study, we have probed the substrate-
dependent accessibility of several residues in the 
substrate translocation pathway, including several 
positions in the re-entrant hairpin loops of 
VcINDY; M157 and T154 in HP1, and S381, L384, 
and V388 in HP2 (Fig. 8A). Interestingly, we 
observe different effects of coupling ion and 
substrate binding within the same hairpin. As with 
other tested positions, T154 and S381 are mostly 
sensitive to the presence of Na+, whereas L384, 
V388, and in particular M157 exhibit considerable 
sensitivity to the presence of succinate (Fig. 5C). 
While further experimental work is required to 
provide a full picture of the dynamics of VcINDY’s 
re-entrant hairpins, these results suggest discrete 
effects of the coupling ion and substrate on the 
conformation of the hairpins. This multistep 
mechanism is strongly supported by the recent 
cryo-EM structures of the Na+ bound IFS of 
VcINDY16. Comparing these structures to the Na+ 
and succinate bound IFS of VcINDY reveals 
substantial local structural changes centred around 
the re-entrant hairpin loop, HP116. While an apo 
state structure is required to determine the exact 
structural effects of Na+ binding, these new 
structures reveal that the binding of succinate 
induces conformational changes over and above 
what is induced by Na+ binding; supporting the 
multistep mechanism our alkylation data suggests. 
Analogous to the situation with GltPh and its 
homologues, binding of Na+ is likely required for 
high affinity binding of succinate, and binding of 
the succinate molecule is required to stabilise the 
“closed” conformation of the re-entrant loop, which 
allows the elevator-like conformational change to 
take place23,44-47. The suggestion that the re-entrant 
hairpins undergo conformational changes in 
response to succinate binding is strengthened by the 
observations made during a series of solvent 
accessibility studies on the eukaryotic DASS 
transporter, NaDC120,48,49. In concordance with our 
work presented here, the binding of Na+ and 
succinate had substantial and separable effects on 
the solvent accessibility of residues in the arm of re-
entrant hairpin 2 in NaDC1 (in the same region and 
S381, L384 and V388 in VcINDY), suggestive of 
discrete conformational changes upon each Na+ and 
succinate binding event20,48,49. In contrast to our 
observations with VcINDY, the HP2 re-entrant 
loop residues become more accessible in the 
presence of Na+ alone, and then less accessible 
upon addition of succinate48. The differences 
between these two systems may be explained by the 
experimental set-up; NaDC1 was probed in the 
lipid bilayer, in the presence of gradients and a 
membrane potential, and in a background with 10 
native cysteines present, whereas, in our study, each 
VcINDY variant was detergent-solubilised and 
contained only one cysteine residue. Cysteine 
accessibility studies on another bacterial DASS 
family member, SdcS from Staphylococcus aureus, 
revealed that D329 (F291 in VcINDY), which is 
predicted to be on the outward façade of the protein, 
is accessible in the presence of Na+, but not in the 
absence50. However, the equivalent position of 
VcINDY was not tested in this study. Curiously, the 
same SdcS study, N108 (N94 in VcINDY) was 
shown to be accessible from both the external and 
cytoplasmic sides of the membrane. However, in 
both the IFS crystal structure and the repeat-
swapped model of VcINDY, there is dense protein 
blocking access to this site from the cytoplasmic 
side of the membrane50. This perhaps suggest that 
the mechanism of SdcS is considerably different to 
the current structural model based on VcINDY, or 
that the conformational changes during transport 
are substantially more extreme than currently 
thought. Nevertheless, these studies combined 
suggest that there are discrete conformational 
changes upon binding Na+ and succinate to DASS 
transporters. Indeed, solvent accessibility studies 
on NaDC1 prior to the elucidation of the structure 
of VcINDY revealed that the accessibility changes 
in HP2 were temperature insensitive, indicative that 
the modulation in accessibility was not due a large 
conformational change, but perhaps due to 
blockade of these possible binding site residues by 
succinate48. However, our current structural 
understanding of the DASS family reveals that 
these residues are in the arm of HP2 and do not 
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form part of the binding site. Therefore, these 
observed accessibility changes of HP2 residues 
could be explained by subtle, local conformational 
changes of the hairpin in response to succinate 
binding. More structural information is required to 
fully realise the DASS transporter mechanism, in 
particular, a structure of the apo state of VcINDY 
will be especially illuminating. The substrate-
dependent effects on the accessibility of HP2 
residues for VcINDY and NaDC1 suggest that local 
hairpin movements are a feature of both 
transporters and is indicative of a shared transport 
mechanism. Indeed, the generation of homology 
models of NaDC3’s IFS and NaDC1’s IFS and OFS 
(based on the IFS structure and OFS model of 
VcINDY) reveals a shared overall architecture and 
shared Na+ and substrate binding sites20,51. In 
addition, these models identified residues in 
NaDC1 that potentially form a discrete OFS 
binding site that would be formed by the action of 
the proposed elevator mechanism; mutation of the 
residues diminished Na+ and succinate transport 
activity, supportive of a unified elevator 
mechanism for the DASS transport family. 
Furthermore, a recent study of human NaDC1 and 
NaCT identified a cluster of positively charged 
residues, conserved in the SLC13 family, that 
appear to strongly influence transport activity, with 
R108 (V118 in VcINDY) proving to be 
indispensable for transport activity52. These 
residues are predicted, based on the structures of 
VcINDY, to form a short helix on the cytoplasmic 
façade of the scaffold domain. While these residues 
do not appear to contribute directly to binding site 
formation, they are hypothesised to interact with 
HP1 during the elevator-like transport cycle52, 
perhaps playing a role in stabilising a particular 
ligand-bound state. We note with interest that the 
equivalent helix in VcINDY contains multiple 
charged residues and that the cysteine accessibility 
assay data presented here demonstrates that 
accessibility to a residue in this helix (A120) is 
highly sensitive to the presence of Na+. These data 
combined reveal a more complex picture of 
transport regulation in the DASS family that 
requires further investigation to fully realise.  
 
Substrate binding appears to be ordered and low 
affinity. In this study, we have identified a position 
in the arm of HP1, M157, whose accessibility is 
insensitive to the addition of Na+, but undergoes 
substantial accessibility changes in the presence of 
succinate (Fig. 5C and 6A). Probing this mutant in 
more detail, we discovered that the accessibility 
effects were only induced by the addition of 
compounds known to be transportable by VcINDY, 
for example, succinate, malate and fumarate, 
demonstrating specific binding was required (Fig. 
7). In addition, we did not observe any changes in 
accessibility upon addition of succinate in the 
absence of Na+, demonstrating that Na+ must bind 
first before succinate can bind, as has been 
suggested in previous studies on DASS 
transporters53. This ordered binding is consistent 
with other Na+-driven elevator transporters. The 
archetypal elevator transporter, GltPh, transports 
aspartate coupled to the co-transport of 3 Na+ 
ions54,55, with 2 Na+ ions binding first to the apo 
transporter to ‘prime’ the binding site before the 
aspartate and final Na+ bind47,56,57, allowing the 
hairpin to close and the OFS-to-IFS transition to 
occur. Our data suggest a similar ordered binding 
mechanism for VcINDY. However, more detailed 
analysis of the coupling ion and substrate binding is 
required to illuminate this process further.  
When titrating succinate and monitoring the dose-
responsive change in modification of 
VcINDYM157CIFS, we only observed substantial 
shifts in the modification efficiency once the 
succinate concentration reached ~100 µM (Fig. 
6B). This concentration is surprisingly high 
considering VcINDY’s Km for succinate transport 
in proteoliposomes in the presence of a similar Na+ 
concentration is 1 µM15. To put this in the context 
of other elevator-like transporters; GltPh also has Km 
for transport of ~1 µM58,59, but has a Kd of 100 
nM47. Since VcINDY and GltPh have a similar 
mechanism and identical Kms, it is not unreasonable 
to predict they would have similar Kds. However, if 
this were the case, we would expect VcINDY’s 
binding site to be saturated at 100 µM; the fact that 
the we continue to observe decreases in the 
modification rate with increasing succinate 
concentration demonstrates that it is not. We 
confirmed separately, using MST, that wildtype 
VcINDY has a succinate Kd in the mM range, 
revealing that our alkylation assay was a reasonable 
reporter of substrate affinity, and demonstrated that 
the observed low affinity was not caused by 
deleterious effects of the cysteine mutation on 
substrate interactions. Transporters with Kms lower 
than their Kd are rarely observed. However, one 
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notable example is CaiT, which has a Km of ~80 µM 
and Kd of ~3 mM60. CaiT’s apparent low affinity is 
due to the protein containing more than one 
functionally significant substrate binding site60. 
Due to the positioning of the substrate at the 
interface of the scaffold and transport domains in 
the crystal structures of VcINDY, we predict that 
VcINDY also contains at least two disparate 
binding sites; functional studies of NaDC1 also 
support this hypothesis20. In addition, a 
pharmacological study of human NaCT suggests 
multiple substrate binding sites61. Therefore, the 
apparent low affinity we observe in this study is 
likely a consequence of multiple substrate binding 
sites and is potentially of mechanistic importance. 
While the results presented in this study indicate 
that alkylation rate analysis can give a reasonable 
approximation of substrate affinity, it is important 
to consider that cysteine accessibility assays are not 
precise reporters of substrate affinity. Firstly, 
cysteine reactions may not reach completion due to 
side reactions of cysteines (e.g. oxidation) that 
render a population unreactive28. Secondly, the 
protein could contain multiple substrate-bound 
states that may not provide equal access to the 
cysteine being probed. The latter case is of 
particular significance for transporters, whose 
mechanisms are frequently highly dynamic and 
consist of multiple well-populated 
conformations62,63. Alternatively, this apparent low 
affinity may be due to VcINDY being in a 
detergent-solubilised state with further functional 
analysis in the presence of a lipid bilayer needed to 
resolve this issue. However, the fact the our purified 
VcINDY can specifically bind both Na+ and 
succinate, discriminating against structurally 
related non-substrates of VcINDY, which requires 
the formation of specific binding pockets, suggests 
that the binding sites are well formed in these assay 
conditions.  
We performed this study on detergent-solubilised 
protein in order to make the results directly 
comparable to the crystal structure of VcINDY, 
which was crystallised in its detergent solubilised 
form. In addition, we selected our panel of single 
cysteine mutants based on the crystal structure and 
repeat-swapped model of VcINDY in order to 
report on the these particular conformations.  
Using lipid bilayer mimetics, such as detergents, 
may produce different results to what is seen in a 
membrane environment, where there is an absence 
of lateral pressure, other membrane proteins, 
specific protein:lipid interactions and 
electrochemical gradients. Indeed, single molecule 
FRET (smFRET) experiments have demonstrated 
that GltPh has appreciably different dynamic 
behaviour in detergent micelles versus lipid 
bilayer41,64. However, we have demonstrated using 
two of our VcINDY mutants, one with an IFS-
accessible cysteine (M157C) and one with an OFS-
accessible cysteine (A120C), that the effects of 
substrate on accessibility in detergent mirror the 
substrate effects in the lipid bilayer of native 
nanodiscs (Fig. 5). In addition, site-directed 
alkylation studies on other transport proteins have 
shown directly that substrate-induced alkylation 
rates changes are similar in detergent compared to 
those measured in lipid bilayer65. These data 
combined give us confidence that the qualitative 
differences we observe in the presence and absence 
of substrates are mechanistically relevant. The 
elevator-like mechanism requires large-scale 
conformational changes, which is almost certainly 
affected by the lipid composition (both lipid head 
group and hydrocarbon chain length and 
saturation). The dynamics and overall transport rate 
of the only other well characterised elevator-like 
transport, GltPh, is influenced by the presence and 
composition of the lipid environment and 
molecular dynamic simulations have recently 
shown large-scale bilayer deformation can be 
induced by elevator-like transporter conformational 
changes41,64,66-69. So, aside from any specific 
protein:lipid interactions that may be influencing 
VcINDY’s function, the physical properties (e.g. 
flexibility) of the bilayer, which is dictated by the 
lipid composition, will clearly have a strong effect 
on its mechanism. How the lipid environment and 
electrochemical gradients across bilayers 
influences protein dynamics and substrate-
dependent conformational changes of VcINDY is 
of great interest and is the subject of ongoing 
studies in our lab. 
 
Potential implications to the mechanism of 
VcINDY. While further work is needed to fully 
realise the dynamics of VcINDY, our data are 
consistent with VcINDY having a complex 
mechanism that consists of multiple large-scale and 
local conformational changes as described by the 
following hypothetical mechanistic scheme (Fig. 
8B). For simplicity, we will start this transport cycle 
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with VcINDY in its OFS. However, as VcINDY is 
a secondary-active transporter, it has the ability to 
work in the reverse direction depending on the 
direction and magnitude of the electrochemical 
gradients. In the OFS conformation (Fig. 8B, state 
i), VcINDY is initially ligand free and the overall 
architecture resembles the structure described by 
the repeat swapped model21. One or more Na+ ions 
bind (for simplicity, we are showing 3 Na+ 
binding), stabilising a conformation of the transport 
domain in which HP2 is open and the binding site 
is primed to bind succinate (Fig. 8B, state ii). 
Succinate binds in the primed site (Figure 8B, state 
iii), which stabilises the “closed” state of HP2 (Fig. 
8B, state iv), allowing the transport domain to move 
into the closed IFS (Fig. 8B, state v). HP1 opens 
(Fig. 8B, state vi), releasing the substrates into the 
cytoplasm (Fig. 8B, state vi and vii). HP1 closes 
and the ligand-free transport domain can 
translocate to form the OFS and restart the cycle. 
Overall, this work reveals the existence of 
substrate-dependent conformations of VcINDY 
that are likely crucial to its tightly coupled Na+-
driven transport mechanism and sheds light on an 
important facet of the DASS transporter 
mechanism that may have implications in the 
development of state-dependent inhibitors of this 




Molecular biology and cysteine mutants 
generation. All single cysteine variants were 
generated in a previously characterised cysteine-
free background in which all three native cysteines 
had been substituted for serine15. Substitutions were 
made with a Quikchange II site-directed 
mutagenesis kit (Agilent Technologies). 
Expression plasmids were fully sequenced to 
ensure that the desired codon substitution occurred 
and no unwanted secondary mutations were 
introduced. Cysteine mutants were selected based 
on the IFS crystal structure of VcINDY (PDB ID: 
4F35)17, and the OFS model that was based on this 
structure21. 
 
Expression of VcINDY. Over the course of this 
work, we modified the expression protocol of 
VcINDY three times in an effort to maximise its 
yield, which led to an increase in yield from 0.2 
mg/L culture to >5 mg/L culture for wildtype 
VcINDY. Changes in expression levels of VcINDY 
did not affect the quality of the protein produced, 
the PEGylation efficiency for each variant, nor the 
transport activity of each variant (data not shown). 
In all three protocols, VcINDY and its variants 
were expressed in-frame with an N-terminal 
decahistidine tag form a modified pET vector70. 
VcINDY was initially expressed as described 
previously15,17. Briefly, BL21-AI (Invitrogen) cells 
harbouring the expression vector were grown in LB 
supplemented with 50 µg/ml kanamycin and 
incubated at 37oC until it reached an A600 of 0.8. 
Cells were rapidly cooled in an ice bath for 20 min, 
at which point expression was induced by addition 
of 10 µM IPTG and 6.6 mM L-arabinose. The cells 
were incubated at 19oC and grown for 
approximately 16 hours before being harvested and 
resuspended in Lysis Buffer (50 mM Tris, pH 7.5, 
200 mM NaCl, and 10% (v/v) glycerol). Following 
disappointing yields via the above method, we 
adopted the MemStar method described by Drew 
and co-workers71. Briefly, in this protocol, Lemo21 
(DE3) (New England Biolabs) cells harbouring the 
expression plasmid were grown in PASM-5052 
media72, which was supplemented with 50 µg/ml 
kanamycin and 25 µg/ml chloramphenicol and 
incubated at 37oC until it reached an A600 of 0.5. At 
this point, expression was further induced by the 
addition of 0.4 mM IPTG and the cells were 
incubated for approximately 16 hours at 25oC 
before being harvested and resuspended in Lysis 
Buffer. 
The following small modifications to this protocol 
increased the yield of VcINDY approximately 10-
fold; the PASM-5052 media was exchanged for the 
MDA-5052 and the kanamycin concentration was 
increased to 100 µg/ml. These changes likely led to 
an increase in VcINDY yield because of better 
maintenance of the kanamycin resistant expression 
plasmid in the Lemo21 (DE3) cells. Lemo21 (DE3) 
(and other BL21 derivatives) grow robustly in high 
levels of kanamycin in high phosphate media, such 
as PASM-505272, whereas, in MDA-5052 media, 
which contains half the phosphate concentration, 
Lemo21 are again sensitive, making the antibiotic 
selection of expression plasmid-containing cells 
more effective. 
 
Purification of VcINDY. VcINDY was purified as 
detailed previously15. Briefly, resuspended cells 
were lysed by sonication, the lysate was clarified by 
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centrifugation at 20000 xg for 20 min, and the 
membrane fraction was isolated by 
ultracentrifugation at 200000 xg for 2 hours. 
Membrane vesicles were resuspended in 
Purification Buffer (50 mM Tris, pH 8, 100 mM 
NaCl, 5% (v/v) glycerol). For the purification of 
cysteine containing variants of VcINDY, the 
Purification Buffer was supplemented with 0.5 mM 
tris-(2-carboxyethyl)phosphine (TCEP) to keep the 
cysteines in a reduced state. 0.5 mM TCEP was 
added to all purification buffers. VcINDY was 
solubilised by incubating the vesicles with 19.6 
mM n-dodecyl-β-D-maltopyranoside (DDM, 
Glycon) for 1 hour at 4oC. Non-solubilised material 
was removed by ultracentrifugation and the soluble 
fraction was incubated with Talon metal affinity 
resin (Takara Bio) for 16 hours at 4oC. Loosely 
bound contaminants were eluted from the resin and 
the detergent exchanged by 2 rounds of washing 
using Purification Buffer supplemented with 1.96 
mM DDM and 10 mM imidazole, followed by 
Purification Buffer containing 5.4 mM n-decyl-β-
D-maltopyranoside (DM, Glycon) and 20 mM 
imidazole. Protein was eluted by incubating the 
resin with Purification Buffer supplemented with 
5.4 mM DM and 10 µg/ml trypsin for 1 hour at 4oC. 
The purified protein was concentrated and stored at 
-80oC. Styrene maleic acid (SMA)-extracted 
VcINDY was purified in the same way except the 
protein was extracted by incubation with 3% (w/v) 
3:1 SMA at room temperature for 1 hour, detergents 
were withheld from all buffers and the protein-
bound resin was washed with 5 mM imidazole. All 
cysteine-containing protein were stored in the 
presence of TCEP to keep the cysteines reduced. 
 
Protein reconstitution. Protein was functionally 
reconstituted as detailed previously21. 25-100 µg of 
DM-solubilised and purified protein was diluted to 
2 ml in Reconstitution Buffer (25 mM Tris, pH 8, 
100 mM NaCl, 5% glycerol and 3% DM) and 
mixed with 400 µl 20 mg/ml E. coli polar lipids 
(Avanti Polar Lipids). This mixture of protein/lipid 
was incubated on ice for 10 min followed by rapid 
dilution into 65 ml of Inside Buffer (20 mM Tris, 
pH 7.5, 1 mM NaCl, 199 mM KCl, and 1 mM 
DTT). The resultant proteoliposomes were 
collected by ultracentrifugation, resuspended in 
Inside Buffer to a concentration of 8 mg/ml lipid, 
freeze thawed thrice, and stored at -80oC.  
 
In vitro transport assays. For transport assays, the 
required amount of proteoliposomes were thawed, 
extruded 11 times through a 400 nm filter, collected 
by ultracentrifugation, and resuspended to a final 
concentration of 80 mg/ml lipid. Transport assays 
were performed by rapidly mixing the prepared 
proteoliposomes with Reaction Buffer (20 mM 
Tris, pH 7.5, 100 mM NaCl, 100 mM KCl, 1 µM 
valinomycin, and 1 µM [3H]-succinate (American 
Radiolabelled Chemicals). At frequent timepoints, 
samples were collected from the transport reaction 
and quenched by addition of ice cold Quench 
Buffer (20 mM Tris, pH 7.5, 200 mM ChCl). 
Proteoliposomes and the accumulated [3H]-
succinate were collected by rapid filtration through 
200 nm nitrocellulose filters (Millipore). The filters 
were washed with 3 ml of Quench Buffer, dissolved 
in FilterCount liquid scintillation cocktail 
(PerkinElmer) and the accumulated [3H]-succinate 
was counted using a Hidex 300SL Liquid 
Scintillation Counter. 
 
PEGylation timecourse. To perform the 
PEGylation timecourse, detergent solubilised 
protein was thawed and buffer exchanged using 
Zeba Spin Desalting Columns (Thermo Fisher 
Scientific) to remove the 0.5 mM TCEP and 
exchange the protein into PEGylation Buffer (50 
mM Tris, pH 7, 5.4 mM  DM, 5% (v/v) glycerol). 
For PEGylation of SMA-extracted protein, the 
same PEGylation buffer was used, but without the 
DM. The substrate-free apo sample was formulated 
by mixing protein solution with 1 M KCl and 
PEGylation Buffer to generate a final protein 
concentration of 10 µM and a final KCl 
concentration of 150 mM. The “Na+ alone” sample 
was formulated in the same way except KCl was 
substituted for NaCl. The same approach was used 
for the “Na+ + succinate” samples except that 
succinate was added to a final concentration of 1 
mM. For the “succinate alone” sample, protein was 
mixed with 150 mM KCl and 1 mM succinate. The 
protein/substrate mixtures were incubated for at 10 
minutes at room temperature, at which point the 
PEGylation reaction was started by addition of 
either 0.4 or 5 mM methoxypolyethylene glycol 
maleimide 5K (mPEG5K) (Sigma Aldrich) for 
detergent and SMA-solubilised samples, 
respectively. Samples were collected at various 
timepoints and the reaction was terminated by 
addition of SDS-PAGE sample buffer containing 
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100 mM methyl methanethiosulfonate (MMTS) 
(Sigma Aldrich). The PEGylation reaction samples 
were analysed using non-reducing polyacrylamide 
gels, which were stained with Coomassie Brilliant 
Blue dye to visualise the protein.  
 
Densitometric analysis. The intensities of the 
bands corresponding to the unmodified and 
PEGylated VcINDY protein bands were quantified 
using ImageJ software73,74. For each timepoint, the 







For the final data sets, replicates (n≥3) of the 
modification efficiency for each timepoints were 
averaged and the standard error of the mean (SEM) 
was calculated. Where indicated, statistical 
significance was examined using unpaired t-tests. 
 
Microscale Thermophoresis (MST) assay. For 
the MST assays, substrate stock solutions were 
produced by dissolving substrates in MST Assay 
Buffer (50 mM Tris, pH 7, 10% glycerol) and pH 
adjusted to pH 7 with either KOH. His-tagged 
VcINDY was labelled using the NanoTemper 
RED-tris-NTA dye and diluted to 500 nM in MST 
Assay Buffer containing 300 mM NaCl. Labelled 
VcINDY was mixed in 1:1 ratios with various 
substrate dilutions and incubated at room 
temperature for 5 min before loading into capillary 
tubes. MST was performed using the NanoTemper 
Monolith NT.115. Standard binding affinity 
protocols in the MO.Control software were used. 
∆Fnorm represents the proportion of the initial 
fluorescence remaining in the path of the laser at 4-
5 s after heating begins. ∆Fnorm values were fitted 
to a sigmoidal curve and Kd was estimated using 






All data are contained within the manuscript. 
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Table 1. List of VcINDY cysteine variants produced during the course of this work. For each variant, 
it is indicated whether the protein could be stably expressed, whether it was active in in vitro transport 












E42C Yes Yes Yes No 
F79C Yes Yes No - 
A120C Yes Yes Yes Yes 
W148C Yes Yes No - 
T154C Yes Yes Yes Yes 
M157C Yes Yes Yes Yes 
T177C Yes Yes Yes Yes 
Y178C Yes Yes No - 
A206C No - - - 
A208C Yes Yes No - 
S213C No - - - 
T215C Yes Yes Yes Yes 
V272C Yes Yes No - 
A346C Yes Yes No - 
V364C Yes Yes No - 
V370C Yes No - - 
F375C Yes No - - 
S381C Yes Yes Yes Yes 
A383C Yes No - - 
A384C Yes Yes Yes Yes 
V388C Yes Yes Yes Yes 
T391C No - - - 
G430C Yes Yes No - 

































Figure 1. Structure and simple kinetic transport scheme of VcINDY. A) Inward-facing state (IFS, left) 
crystal structure (PDB: 4F35) and outward-facing state (OFS, right) model of VcINDY. Transport domain 
is depicted as orange helices and the scaffold domain is blue. Bound substrate is yellow spheres; the bound 
Na+ ion is a magenta ball; membrane is indicated by the grey rectangle. B) Simple kinetic model of transport 
by VcINDY. Substrate-free OFS (top left) binds Na+ and succinate2- in an unknown order (step 1), at which 
point the transporter transitions from OFS to IFS via an occluded state (steps 2 & 3). Substrates are released 
into the inside of the cell (step 4), and the empty transporter undergoes a conformational change back to 
































Figure 2. Probing solvent accessibility of substituted cysteines. A) Cartoon representation of VcINDY 
in its outward-facing state (OFS, left) and inward-facing state (IFS, right) depicting the change in solvent 
accessibility of a single substituted cysteine (pink spheres) in these different conformations. Cysteines that 
are more solvent exposed will react more readily with the mPEG5K (red spheres) resulting in increased rate 
of PEGylation. VcINDY’s colour scheme is the same as Figure 1. B) An SDS-PAGE gel depicting the 
gradual modification of a single cysteine residue of VcINDY by mPEG5K. Upon modification with 
mPEG5K, the apparent molecular weight of VcINDY increases from ~38 kDa to 43 kDa. Band intensity is 
quantified by densitometry. C) Graph of the modification efficiency of the VcINDY cysteine mutant as a 


































Figure 3. Substrate-induced accessibility changes in VcINDY. A) A merge of the structures of the 
outward-facing state (OFS, left of the dotted line) and the inward-facing state (IFS, right of the dotted line) 
illustrating the relative accessibility of the single substituted cysteine residues (red spheres); T154C (left 
panel), S381C (middle panel), and E42C (right panel) in each conformation. The colour scheme used for 
VcINDY is the same as in Figure 1. B) Representative SDS-PAGE gels of PEGylation timecourse of the 
single cysteine mutants T154C (left panel), S381C (middle panel), and E42C (right panel) in the presence 
(bottom gel) and absence of substrates (top gel). The PEGylated protein bands (P) and unmodified protein 
bands (U) are indicated by arrows. C) Proportion (%) of each single cysteine mutant modified at each 
timepoint in the presence (grey data) of saturating Na+ and succinate and in apo conditions (blue data). Data 
points are the average of triplicate datasets and the error bars represent SEM. This experiment was 

















Figure 4. Summary of the effects of the addition of substrates (Na+ and succinate) on the accessibility 
of all single cysteine mutants. A) IFS X-ray structure of VcINDY showing the positions of each single 
cysteine substitution used in this analysis. Colour scheme is the same as Fig. 1. Each of the positions 
mutated to cysteine are shown in red spheres. B) Change in modification efficiency (∆modification 
efficiency) is the difference between the modification efficiency at the 60 min timepoint in the presence 
and absence substrates. Using the value obtained in the absence of substrates as a baseline, a negative value 
indicates lower modification efficiency in the presence of substrate; and a positive value indicates higher 
substrate-induced modification efficiency. Grey bars are the predicted IFS accessible mutants, the open 
bars are the predicted OFS-accessible mutants, E42C is the control. Individual datapoints are shown (open 
circles), each bar is an average of the individual data sets and the error bars indicate SD. This experiment 












Figure 5. Effects of individual substrates on the single cysteine modification efficiency. Proportion (%) 
of A) VcINDYT154C and B) VcINDYS381C that is modified at each timepoint in the presence of Na+ 
alone (red data) or succinate alone (black data). Modification rate of each mutant in the presence and 
absence of saturating substrates (same data presented in Fig. 3) is shown as dashed lines for comparison 
(grey and blue data, respectively). Data shown is the average of 3 datasets and error bars indicate SEM. C) 
Summary of the effects on the modification rates for each mutant of Na+ alone (red column) compared to 
the overall effect of Na+ and succinate (grey column). The data are an average of two data sets for M157C 
and 3 data sets all other mutants. Individual datapoints are shown (open circles) and error bars indicate SD. 
This experiment was performed for each mutant at least 3 times. D) Proportion (%) of VcINDYA120C in 
native nanodiscs modified in the presence of no substrate (K+-containing buffer, blue data) and Na+ alone 
(red data). E) Proportion (%) of VcINDYM157C in native nanodiscs modified in the presence of Na+ alone 
(red data) and Na+ + succinate (grey data). Individual datasets are shown for experiments in D and E, which 




























Figure 6. Effects of substrates on the modification efficiency of VcINDYM157CIFS. A) Modification 
efficiency (%) of VcINDYM157CIFS at each timepoint in the presence of no substrate (150 mM K+, blue 
data), Na+ alone (red data), succinate alone (black data), and Na+ + succinate (grey data). B) Modification 
efficiency of VcINDYM157CIFS in the presence of 150 mM NaCl and increasing concentrations of 
succinate from 0-1 mM. The data are an average of at least 3 data sets for A) and two data sets for B). C) 
MST-based binding analysis of VcINDY for succinate (red data) and non-substrate, oxalate (black data). 
Succinate data are an average of 3 data sets and a single dataset is shown for oxalate. Error bars indicate 



















Figure 7. Effects of substrates on the modification efficiency of VcINDYM157CIFS. A) Proportion (%) 
of modified VcINDYM157CIFS at each timepoint in the presence of 150 mM Na+ and no substrate (blue 
data), oxalate (red data), malate (black data), or succinate (grey data). B) Chemical structures of the 
compounds used in A) and B); succinate, fumarate, malate, oxaloacetate, citrate, oxalate. C) Normalised 
modification efficiency of VcINDYM157CIFS after 1 hour in the presence of 150 mM NaCl and either 1 
mM (open bars) or 10 mM (closed bars) of each indicated compound. The data are an average of at least 3 
data sets, individual datapoints are shown (open circles) and the error bars indicate SD. This experiment 





























Figure 8. Position of succinate-sensitive hairpin residues and a hypothetical mechanism of VcINDY. 
A) Section of the X-ray structure of VcINDY’s transport domain highlighting HP1 (red), HP2 (purple) and 
the three positions particularly sensitive to the presence of succinate (teal). The substrate (citrate, yellow 
sticks) and Na+ ion (purple sphere) are shown. B) Hypothetical mechanism of VcINDY. OFS VcINDY 
binds Na+ ions (i), which stabilises an open state of HP2 (ii); succinate binds (iii), which stabilises the 
closed state of HP2 (iv), allowing the protein to transition to an inward-closed state (v); HP1 opens (vi); 
coupling ions and substrate are released into the cytoplasm (v & vi); empty transporter (viii) transitions 
back to the OFS to restart the cycle. Colour scheme is the same as A). Movement of hairpins and transport 
domains signified by colour-matched arrows. 
 
 
 
